EP1135523A1 - Detection de sous-especes du mycobacterium avium - Google Patents

Detection de sous-especes du mycobacterium avium

Info

Publication number
EP1135523A1
EP1135523A1 EP99958512A EP99958512A EP1135523A1 EP 1135523 A1 EP1135523 A1 EP 1135523A1 EP 99958512 A EP99958512 A EP 99958512A EP 99958512 A EP99958512 A EP 99958512A EP 1135523 A1 EP1135523 A1 EP 1135523A1
Authority
EP
European Patent Office
Prior art keywords
nucleic acid
mycobacterium avium
detection
subspecies
mycobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99958512A
Other languages
German (de)
English (en)
Inventor
Frederik Schut
Henriette Zwaantina Ensing
Hendrik Hiddo Koopmans
Paris Som Tjwan Tan
Lucas Hendrik Albert Wagter
Johannes Michiel Anthonius Brinkhof
Cornelis Van Maanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gezondheidsdienst voor Dieren
Microscreen BV
Original Assignee
Gezondheidsdienst voor Dieren
Microscreen BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gezondheidsdienst voor Dieren, Microscreen BV filed Critical Gezondheidsdienst voor Dieren
Priority to EP99958512A priority Critical patent/EP1135523A1/fr
Publication of EP1135523A1 publication Critical patent/EP1135523A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Definitions

  • the invention relates to the field of microbiology, more specifically to the field of detection and identification of pathogenic micro-organisms, more specifically to the detection and identification of Mycobacterium avium subspecies para tuberculosis, an agent which causes Johne ' s disease in many ruminants.
  • Mycobacteria are aerobic, Gram-positive, acid-fast rod-shaped bacteria (0.2-0.6 x 1.0-10 ⁇ m) .
  • the genus as a whole is characterised by long-chain mycolic acids in the cell-wall. Large amounts of lipids in the cell-wall result in remarkable resistance to de-staining of stained cells, which forms the basis of the Ziehl-Neelsen staining used to identify Mycobacteria.
  • Mycobacteria are slow- growing organisms.
  • Mycobacterium avium subspecies para tuberculosis is ranked as an extremely slow growing organism. Many attempts have been made to improve the cultivation conditions. Further possibilities to significantly improve the growth rate of the bacterium in vitro are virtually absent.
  • the taxono ic position of Mycobacterium avium subspecies para tuberculosis is defined on 16S ribosomal RNA sequence data (1) .
  • the bacterium is a member of the Mycobacterium avium complex (MAC) .
  • MAC Mycobacterium avium complex
  • This complex is composed of Mycoba cterium avium, represented by the three subspecies avium, silva ticum and para tuberculosis , and of Mycobacterium intracell ulare (2) .
  • Mycobacterium avium subspecies para tuberculosis is, among others, characterised from the other bacteria in this complex by its requirement for mycobactin in the growth medium (3) .
  • Paratuberculosis or Johne ' s disease is a world-wide occuring disease caused by the bacterium Mycobacterium avium subspecies para tuberculosis .
  • An estimated 30-40% of the cattle farms in The Netherlands is affected by this disease and approximately 2% of all cows in The Netherlands is infected with this bacterium.
  • the total damage as a result of the disease (loss of milk production, mortality and restrictions in trade) is estimated at 45 million Dutch guilders per annum with a damage of 50 to 300 guilders per cow per annum on the affected farms. At this moment, infected animals generally are, once detected, culled or removed from the farm and generally destroyed.
  • Johne ' s disease is thought to be related to the inflammatory bowel syndrome in humans, also known as Crohn ' s disease. If the causal agent of Johne' s disaese is indeed also a casual of inflammatory bowel syndrome in humans, the disease may well be placed on the list of animal to human transmissible diseases or zoonoses.
  • the detection of cattle infected with Mycobacterium avium subspecies para tuberculosis is hampered by two important factors: i) The clinical symptoms of illness are first detectable after an incubation period of four to five years. Due to the slow progression of the infection and slow development of an immune response, testing before the second year in the life of a cow is therefore in general not even considered useful, ii) The bacterium itself propagates extremely slow as a result of which the only currently reliable test to identify the bacterium - a conventional cultivation of faecal samples - requires up to 6 months. Furthermore, testing only once does not suffice. A minimal sampling rate of two times per year per farm is necessary to ensure effectiveness of the eradication program.
  • the BACTEC system for the detection of Mycobacterium avium subspecies para tuberculosis is a revision of the BACTEC system for the detection of M. tuberculosis in humans (Becton Dickinson Diagnostics) that is used in general hospitals.
  • the BACTEC growth medium is supplemented with specific components to allow growth of Mycobacterium avium subspecies para tuberculosis in the cultivation tubes.
  • the method is more rapid (7 weeks) and more sensitive than conventional cultivation, but is also much more expensive. In order to apply this method on a large scale (1.000 samples/day) approximately 300 BACTEC incubators are required.
  • the 5 tests that are used to detect an immune response against the bacterium Myb . avium subsp. para tuberculosis are i) the complement fixation (CF) test, ii) agar gel immunodiffusion (AGID) test (specific for sheep) , iii) ELISA test on blood-serum (USDA-licensed) , iv) ELISA on milk, v) gamma interferon test (USDA-licensed) .
  • Immunological tests (among which are the serological and cellular immune-mediated assays) for the detection of paratuberculosis are generally not considered satisfactory with respect to sensitivity and specificity, especially in the case of diagnosis in sub-clinically infected animals. Often in serological tests, false-positive results are found due to cross-reactivity with similar antigens in other mycobacteria or related organisms. False-negative reactions occur in the case of so-called "serological non-responders"; animals in the terminal stage of the disease are often anergic. Also, antibody responses develop very slowly. Before three years of age, a very limited percentage of infected animals develop a humoral immune response, and some do not develop an immune response at all.
  • the Idexx Laboratories ELISA test on blood serum exhibits a specificity (percentage animals that is free of infection and tests negative) of 99% and a relative sensitivity (percentage of M. para tuberculosis-infected animals that tests positive) of 45% in "sub-clinically" infected animals (in this case cultivation results are taken as 100%) .
  • the relative sensitivity increases to approximately 85%. Only animals of age 20 months and older can be tested reliably for paratuberculosis with this test. In younger animals the test is too insensitive unless the animals show clinical signs of infection.
  • the interpretation of the test results is quantitative (increase in optical density in the ELISA) and is proportional to the antibody density in the animal's blood.
  • High scores are strongly indicative of infection and possible shedding of bacteria in faeces and milk.
  • a confirmation test (re-testing) must occur within 6 to 12 weeks. The test can, however, not be applied to animals that have received vaccination against Johne ' s disease as this results in false-positive test results.
  • the system is suitable for large scale testing but cannot be considered as an indisputable evidence of infection.
  • the detection of gamma interferon is a cellular immune response assay.
  • the method for determination of interferon release by white blood-cells as a result of Johnin-PPD stimulation is available as a diagnostic kit licensed by the US Department of Agriculture (USDA) .
  • nucleic acid probe-tests for the detection of Myb avium subsp. para tuberculosis has, albeit at first sight a possible alternative for conventional cultivation, proven to be practically quite unfeasible. For one, this is due to the extreme nucleic acid homologies that exist between Myb avium subsp. para tuberculosis and other Myb avium subspecies, which are commonly found in samples such as feacal samples of ruminants (McFadden, J.J., et al. 1987b. J. Gen. Microbiol. 133:211-213; Saxegaard, F., and I. Baess. 1988. Acta Pathol. Microbiol. Immunol. Scand. 96:37-42;
  • nucleic acid-based tests can be directed towards (genomic) DNA or its RNA transcript.
  • genomic DNA Two problems with using genomic DNA as target in DNA amplification methods for diagnostic purpose in general are the low copy number of target molecules per cell and the relative unpredictability of natural sequence variability within the total population of target organisms. More or less related organisms may suddenly show to possess very similar or homologous DNA sequences (Kunze, Z.M., et al . 1991. Mol . Microbiol. 5 (9) :2265-2272; Moss, M.T., et al. 1992. J. Gen. Microbiol. 138:139-145). Such unpredictability limits the reliability through the specificity.
  • the specificity of a nucleic acid based testing .system is determined by the presence of the specific nucleic acid target sequence for hybridisation or the proper identification of the target sites by the probes or primers.
  • the specificity of the test is therefore determined by the genetic variation in the target sequences over the total population of the bacterium to be detected. Knowledge about this variation is therefore important.
  • Mycobacteria are difficult to differentiate on the basis of their genetic makeup due to the presence of exceptional sequence conservation among species (Frothingham, R., et al. 1994. J. Clin. Microbiol. 32 (7) : 1639-1643) .
  • a number of methodologies have been developed to accomplish the distinction between the various species and subspecies.
  • a DNA probe test for the detection of Myb. avium subsp. para tuberculosis is in one case based on the presence of an insertion sequence in the genome of Myb. avium subsp. para tuberculosis thought to be specific for this subspecies, the so-called IS900 sequence (McFadden, J.J., et al. 1987a. Mol. Microbiol. 1:283-291; Vary, P.H., et al. 1990. J. Clin. Microbiol. 28 (5) : 933-937 ) .
  • a PCR reaction is applied for the detection of this para tuberculosis insertion element, which, when present, is present in 15-20 copies on the genome.
  • the IS900 sequence is not present in all strains of Myb . avium subsp. para tuberculosis due to the variation of genomic DNA as described above.
  • a bacterium belonging to the Mycobacterium avium complex that failed to hybridise with a silvaticum-specific probe but was shown to contain the IS900 sequence, or a closely related sequence, as inferred from IS900 PCR (El- Zaatari, F.A.K., et al. 1997. Scand. J. Infect. Dis. 29:202- 204). According to test result for the IS900 sequences, the bacterium should be identified as Mycobacterium avium subsp. para tuberculosis . The possible socio-economic consequences of such findings, however, demand careful interpretation and the authors are accurate when accepting the possibilities of having detected a IS900 homologue or an organism of the avium complex not formerly known to possess the IS900 sequence.
  • results of the IS900 test are, although extremely useful in many cases, not unequivocally interpretable .
  • careful selection of PCR primers is essential to discriminate between IS900 (Vary, P.H., et al. 1990. J. Clin. Microbiol. 28 (5) : 933-937 ) , IS901 (Kunze, Z.M., et al. 1991. Mol. Microbiol. 5 (9) : 2265-2272 ) and IS902 (Moss, M.T., et al . 1992. J. Gen. Microbiol.
  • insertion elements and IS900 hybridisation probes should be employed at utmost stringency to evade the possibilities of erroneously detecting homologous, but dissimilar genetic elements. Consequently, a test based on IS900 testing may also bear the risk of false-positive results, thereby marking cows as infected that are perfectly healthy.
  • samples may be "purified” by using immunomagnetic beads that can specifically "pull" the Myb . avium (subsp. para tuberculosis) cells (Grant, I.R., et al . 1998. Appl . Environ. Microbiol.
  • Probes 12 (3) : 133-142 developed a so-called di-oligonucleotide hybridization (dOH) assay for the simultaneous detection of a Mycobacterium genus-specific recA gene sequence and a paratui-.erculosis-specific 30 bp hspX sequence. All of these alternative tests are based on genomic targets. An important drawback of these genomic methods, however, is related to the low copy number at which these genes or gene sequences occur in the cell. This limits the sensitivity of such tests. To facilitate large scale screening testing for
  • Johne ' s disease with the purpose of eradication several conditions must be met.
  • the test system must be specific for Mycobacterium avium subspecies para tuberculosis and must therefore be able to make a distinction between this subspecies and the other subspecies of the Mycobacterium avium complex that do not cause Johne ' s disease.
  • the specificity of the test no false-positives are wanted due to the fact that positive cows are all destroyed
  • the sensitivity (no false-negatives) of the system must approach that of conventional cultivation methods, otherwise an eradication programme will not be successful. A sensitivity of 100 cells per gram of faeces must at least be reached.
  • the IS900 probe test exhibits such sensitivities under artificial circumstances when tested on M. paratuberculosis-spiked culture-negative DNA samples (Vary et al. 1990. J. Clin. Microbiol. 28:933-937), in direct detection applications in crude bovine manure detection limits lower than 10,000-100,000 cells per gram of faeces are rarely met (Vary et al. 1990. J. Clin. Microbiol. 28:933-937; Van der Giessen et al. 1992. J. Clin. Microbiol. 30: 1216- 1219) .
  • the throughput-rate of the process must be one working day (the total analysis does not necessarily be completed within one day; a certain accumulation of samples can be met) .
  • the assay must allow automation.
  • the system must reach capacities of approximately 1,000 analysis results per day.
  • test result does not necessarily preclude the possibilities of isolating Myb . avium subsp. para tuberculosis from the sample material.
  • the test result is influenced by method of sampling, and transport conditions, variability in the sampling process, laboratory procedural errors, sample miss-identification and, most importantly transcriptional errors.
  • target amplification methods do not present the possibilities to verify the test result.
  • FISH fluorescence in situ hybridization
  • FISH has as a unique advantage that cells are individually visible. However, the direct detection of very low numbers of intact cells of Myb . avium subsp. para tuberculosis in faecal samples is hampered by the high background population (10 10 -10 11 per gram) of other faecal micro-organisms.
  • Mycobacterium avium subspecies avium is prevalent as a normal commensal bacterium in birds, and is relatively widespread.
  • the currently available most sensitive nucleic acid test is the demonstration of the presence of a specific insertion element, IS900, present in the genome of the subspecies para tuberculosis .
  • the sensitivity of this test is too low to allow direct detection of the bacterium in faecal samples or other natural habitats of the bacterium that contain substances inhibitory to enzymatic nucleic acid amplification reactions.
  • the IS900 sequence is sometimes absent in the genome of Mycobacterium avium subspecies para tuberculosis, thereby creating the possibility of a false-negative diagnosis and the IS900 sequence can sometimes be found in the genome of other Mycobacterium avium subspecies, thereby creating the risk of a false-positive diagnosis .
  • the invention provides a method by which a rapid and sensitive procedure for the detection and identification of Mycobacterium avium subspecies para tuberculosis in biological and natural samples is achieved, whereby Mycobacterium avium subspecies para tuberculosis can be discriminated from other Mycobacterium avium subspecies, such as subspecies avium .
  • the invention provides a nucleic acid probe or primer allowing detecting nucleic acid derived from Mycobacterium avium whereby nucleic acid derived from Mycobacterium avium subspecies para tuberculosis can be discriminated from nucleic acid derived from other Mycobacterium avium subspecies.
  • the invention provides a nucleic acid probe or primer allowing detecting nucleic acid derived from Mycobacterium avium whereby Mycobacterium avium subspecies para tuberculosis can be discriminated from other Mycobacterium avium subspecies, said nucleic acid comprising a stable and conserved mutation specific for Mycobacterium avium subspecies paratuberculosis .
  • the invention provides a method for specifically detecting nucleic acid derived from a causal agent of Johne ' s disease in a sample whereby nucleic acid from Mycobacterium avium subspecies para tuberculosis is discriminated from nucleic acid from other Mycobacterium avium subspecies comprising detecting in said nucleic acid a mutation specifically conserved for Mycobacterium avium subspecies para tuberculosis . Said mutation is specifically conserved throughout Mycobacterium avium subspecies para tuberculosis , as opposed to the IS900 insertion sequence, which is sometimes missing or is found in other subspecies.
  • the invention provides a method wherein said nucleic acid is derived from 23S ribosomal RNA, for example wherein said ribosomal RNA comprises a nucleic acid as shown in figure 1, or wherein said conserved mutation is located at position 754, 1363 or 3093 as shown in figure 2.
  • the invention provides three conserved mutations that are present in the functional paratuberculosis 23S rRNA gene sequence. These can be used as diagnostic targets to distinguish between the paratuberculosis and avium subspecies. As such they are part of the present invention in which they are referred to as mutations 754, 1363 and 3093 (figure 2) .
  • ribosomal RNA genes belong to the most stable - or least variant. Due to their role as key elements in protein synthesis, ribosomal RNA's, and consequently the genes encoding them, are highly conserved both in structure and sequence (Pace, N.R., et al . 1985. ASM News 51:4-12).
  • the ribosomal RNA genes comprise a mosaic of variable regions, which allow for discrimination between lower taxa, alternated by sequences that are well conserved, thus allowing for differentiation between higher order taxa (Woese, C.R. 1987. Microbiol. Rev. 51:221-271;
  • ribosomal RNA's Due to the high copy number of mature ribosomal RNA molecules, as a part of the cellular ribosomes, and their predictable, evolutionary regulated, sequence variability, ribosomal RNA' s have become a well established tool in the identification of bacteria. However, among all bacteria, the mycobacteria possess exceptional sequence conservation among species (Frothingham, R. , et al. 1994. J. Clin. Microbiol. 32 (7) :1639-1643) . And the ribosomal RNA's do not represent feasible targets to differentiate between subspecies. Van der Giessen et al.
  • the 16S ribosomal RNA test thus detected both para tuberculosis and avium together and exhibited a sensitivity that was between one and two orders of magnitude lower than the IS900 test (Van der Giessen, J.W.B., et al . 1992. J. Clin. Microbiol. 30 (5) : 1216-1219) . This may be due to the difference in copy number between the ribosomal RNA operon (max 1-3 copies per genome) and the IS900 sequence (15-20 copies). Although the presence of strain-specific sequence differences, based on the comparison of gene sequences from two separate isolates (Van Der Giessen et al. 1994. Microbiology 140:1103-1108), may sometimes mistakenly be interpreted as to yield diagnostically valuable differentiation criteria for closely related species, they do not provide reliable subspecies-level sequence information and may not be used as such.
  • Van der Giessen et al. performed a sequence comparison of the 23S rRNA genes of one strain of para tuberculosis and one strain of avium (Van der Giessen, J.W.B., et al . 1994. Microbiology (UK) 140:1103- 1108). The presence of 9 base differences between the two sequences (3000 nucleotides each) was reported and the possibilities to differentiate the two strains on the bases of these differences was proposed. Also, Stone et al . (Stone, B.B., et al. 1995. Int. J. System Bacteriol.
  • mutations are sequence positions in the 23S rRNA gene of the investigated strains that represent random mutations or natural sequence variability in so far that these mutations do not exhibit evolutionary or phylogenetic significance and for that reason they can not be used for distinctive testing. More such mutations can be found by inter-strain sequence comparison. However, they serve no diagnostic purpose. Such mutations mask the subspecies-specific mutations that are significant to subspecies-specific diagnostics of paratuberculosis .
  • the present invention reveals three point mutations as potential subspecies-specific target-sites that are conserved in all of the 25 investigated reference strains and field isolates of paratuberculosis . Two of these mutations, situated at positions 754 and 1363, are specifically proposed for combined use in a diagnostic test for the subspecies paratuberculosis as these targets are situated in relatively close proximity of one another.
  • Van der Giessen et al suggested the presence of a total of 9 mutations or "mismatches' between the 23S rRNA gene sequences of avium and paratuberculosis. They identified two additional differences between the obtained sequences but these were positioned immediately next to one another in a non-transcribed spacer region and can therefore not be used for sensitive detection as they are non transcribed in functional ribosomal RNA. The conserved status of these "mismatches' remains presently unknown. The nine "mismatches' in the 23S rRNA gene that were identified by Van der Giessen et al . were proposed as potential diagnostic targets.
  • the present invention however reveals that only three conserved mutations are present in the functional paratuberculosis 23S rRNA gene sequence. These can be used as diagnostic targets to distinguish between the paratuberculosis and avium subspecies. As such they are part of the present invention in which they are referred to as mutations 754, 1363 and 3093 (figure 2) .
  • the six remaining targets suggested by Van der Giessen et al . are not conserved (positions 1746,1747, 1843, 2718, 2810, and 3126 respectively in figure 2) .
  • a final mutation identified through the present study is displayed in figure 2 as position 3188. This mutation is part of the internal transcribed spacer region between the 23S and 5S rRNA genes and can not be used for sensitive detection. Its conserved status was recently confirmed by Scheibl and Gerlach (Vet. Microbiol. (1997) 57:151-158).
  • ITS internal transcribed spacer
  • ITS region sequences may sometimes contain insufficient differences (Bourque, S.N., et al. 1995. Appl. Environ. Microbiol. 61 (4) : 1623-1626) . Isolates of Mycobacterium leprae have also been found to contain identical sequences in the ITS region (De Wit, M.Y.L., and O 00/34517
  • the ITS region is not transcribed into functional RNA as a result of which the copy number of this target remains too low to generate improvement of the sensitivity of detection when compared to available tests such as the IS900 probe test.
  • base mutations in the ITS region encounter no evolutionary pressure and mutations can occur quite random and frequent. ITS region mutations are therefore less stable that rRNA gene mutations. This limits the use of ITS sequences to strain level differentiation of Myc. avium complex bacteria (Frothingham. R, et al. 1993. J. Bacteriol. 175 (10) : 2818-2825; Frothingham, R, and K.H. Wilson. 1994. J. Infect. Dis. 169 (2) : 305-312) .
  • the present invention reveals the presence of three stable and conserved mutations in the 23S rRNA of Mycobacterium avium subspecies paratuberculosis which allow the differentiation of this bacterium from other
  • Mycobacteri um avium complex bacteria while at the same time providing for a high copy number target in the form of functionally transcribed RNA.
  • the invention provides a nucleic acid probe or primer wherein said ribosomal RNA comprises a nucleic acid sequence as shown in figure 1.
  • said ribosomal RNA comprises a nucleic acid sequence as shown in figure 1.
  • the ribosomal RNA is present in some 1,000 to 10,000 copies in growing cells and constitute a far more powerful target for direct enzymatic nucleic amplification than the IS900 sequence.
  • the present invention reveals three point mutations as potential subspecies-specific target-sites that are conserved in reference strains and field isolates of paratuberculosis .
  • Two of these mutations, situated at positions 754 and 1363, are specifically proposed for combined use in a diagnostic test for the subspecies paratuberculosis as these targets are situated in relatively close proximity of one another.
  • the present invention shows that these three mutations are conserved and present in the functional paratuberculosis 23S rRNA gene sequence. These can be used as diagnostic targets to distinguish between the paratuberculosis and avium subspecies. As such they are part of the present invention in which they are referred to as mutations 754, 1363 and 3093 (figure 2) .
  • a final mutation identified through the present study is displayed in figure 2 as position 3188.
  • This mutation is part of the internal transcribed spacer region between the 23S and 5S rRNA genes and can not be used for sensitive detection. Its conserved status was recently confirmed by Scheibl and Gerlach (Vet . Microbiol. (1997) 57:151-158). In all, over 60 differences between an individual avium and an individual paratuberculosis strain are identified in the alignment presented in figure 2, of which only three can be used for subspecies-specific diagnostics. Nucleic acid detection generally utilises specific hybridisation of a probe or primer to the nucleic acid to be detected.
  • nucleic detection in general is known in the art and can for example be achieved with classical hybridisation techniques, such as Northern or Southern Blotting on nucleic acid derived directly from a sample or on nucleic acid derived via an amplification process, for example via recombinant DNA techniques wherein said nucleic acid is first amplified, be it indirectly in a host cell, for example in a bacterium such as E. coli using a suitable plasmid system or directly in a suitable amplification system such as PCR or NASBA.
  • Nucleic acid to be detected can also be sequenced directly from the starting material, but more often from nucleic acid that has first been amplified as described above.
  • a probe or primer according to the invention comprises a DNA, RNA or PNA oligonucleotide sequence specific for a Mycobacterium avium subspecies with which said species can be detected in a nucleic acid detection assay.
  • Primers as defined herein, are understood to be unlabelled oligonucleotides, which are selected to start (prime) sequencing or amplification techniques.
  • said sequencing or amplification techniques can be employed to specifically detect a nucleic acid that may or may not be present in a sample, and discriminate it from other, related, nucleic acid sequence that may be present.
  • Probes as defined herein, are understood to be labelled oligonucleotides, which are selected to detect and label the desired nucleic acid, i.e. to report its presence.
  • Probes are in general used to detect a nucleic acid by hybridisation to said nucleic acid, be it by hybridisation to a nucleic acid present in a sample, for example by in si tu hybridisation such as by FISH (fluorescent in si tu hybridisation, or by hybridisation to an amplified fragment of said nucleic acid (also known as an amplicon) .
  • FISH fluorescent in si tu hybridisation
  • amplified fragment of said nucleic acid also known as an amplicon
  • PCR or NASBA derived amplicons for example, can be detected by probing with such a probe, for example by blotting techniques, or by more sophisticated techniques such as Taqman or FRET technology.
  • the invention provides a nucleic acid probe or primer allowing detecting nucleic acid derived from any Mycobacterium avium , such as derived from its various subspecies avium , silva ticum or para tuberculosis , whereby nucleic acid derived from Mycobacterium avium subspecies para tuberculosis can be discriminated from nucleic acid derived from other Mycobacterium avium subspecies, however, in a preferred embodiment, the invention provides a nucleic acid probe or primer according to the invention for detecting a causal agent of Johne ' s disease in a sample, preferably in a sample derived from a ruminant, most preferably from a cow.
  • the invention provides a nucleic acid probe or primer allowing detecting nucleic acid derived from Mycobacterium avium derived from a faecal, blood or milk sample.
  • the invention provides methods and means to detect Mycobacterium avium in samples obtained from animals that may or may not be suspected of having Johne' s disease, allowing discriminating between the various
  • RT-PCR and NASBA are sensitive methods for detection of bacterial ribosomal RNA's.
  • cells of pure cultures suspended in common buffers, such as PBS can be detected at sensitivities of only a few cells per milliliter or gram (see figure 8 of the present invention) .
  • nucleic acid extracts obtained from crude manure of fecal samples exert very strong inhibitory effects on enzymatic amplification of specific nucleic acid sequences both by (RT-)PCR and NASBA (see figure 6 of the present invention) . The reason for this is not fully understood by the art. The result of this, however, is a very low sensitivity of diagnostic assays in fecal samples, due to the necessity of extensive sample dilution.
  • Yet another way, and one that presents an embodiment of the present invention is to use selective lysis and pre- extraction procedures of non-target materials while retaining the target cells or the target nucleic acids in the sample. Due to their extraordinary cellular composition, cells of Mycoba cterium species are very resistant to lysis, at least more resistant than most other bacterial organisms. Specific procedures, separately known to the art to severely disturb cellular integrity, such as repeated freeze-thawing or bead beating with small beads, such as glass beads, are effective ways to lyse most or all cells including those of M. para tuberculosis .
  • the invention thus provides selective lysis of non-mycobacterial organisms or matter to allow better detection of a mycobacterial organism.
  • the resistance to lysis of M. para tuberculosis can be used to increase assay sensitivity.
  • These treatments may include, but are not limited to, TRI-reagent processing of samples (see below) or NaOH exposure. Further examples for the use of such selective lysis treatment and their effect on assay sensitivity are given below.
  • the present invention provides a nucleic acid probe or primer derived from ribosomal RNA, such as 23S ribosomal RNA.
  • RNA target amplification by, e.g., reverse transcriptase PCR (RT-PCR) or NASBA is therefore that these methods are superior in sensitivity than the DNA amplification methods for detection of bacterial cells, e.g., by PCR.
  • RT-PCR reverse transcriptase PCR
  • NASBA NASBA
  • this high copy number is advantageous, since it again allows superior sensitivity.
  • the invention provides a method for detecting nucleic acid derived from Mycobacterium avium in a sample comprising using at least one nucleic acid probe or primer according to the invention.
  • An assay or method as provided by the invention is for example based on the detection of one or more specific point-mutations in the 23S ribosomal RNA of the bacterium.
  • the high copy number of ribosomal RNA's relative to other genomic targets provides for a very high sensitivity of the assay, thereby allowing for performance of the assay in "difficult" matrices , such as faecal, sputum, blood or milk samples.
  • the invention provides a method or assay to detect the bacterium in milk, faeces, soil, feed, and any other habitat in which the bacterium can be found.
  • the speed and ease with which the assay can be performed relative to conventional methods enables one to use it for routine analyses of a large number of samples.
  • Samples can comprise those taken from individuals, such as cows, however, it is also feasible to test bulk or tank milk samples, pooled faecal or pooled blood samples with a method provided by the invention.
  • the invention provides a method for detecting a causal agent of Johne ' s disease.
  • a method or assay as provided by the invention can be used to discriminate between Mycobacterium avium subspecies para tuberculosis and its closest relative Mycobacterium avium subspecies avium .
  • the detection of Myb . avium subsp. para tuberculosis cells in faeces is greatly simplified by a method or assay according to the invention because whole bacterial cells need for example not be detected but DNA or RNA liberated from the cells in the sample is analysed for the presence of specific target or signature sequences.
  • a method as provided by the invention has sufficiently high sensitivity to test faecal samples. Said method can be performed using nucleic acid amplification techniques, or hybridisation techniques, such as si tu hybridisation, for example as described herein.
  • the invention provides a diagnostic kit comprising at least nucleic acid probe or primer according to the invention, and optionally other means, such as buffers and other reagents or instructions, to detect Mycobacterium avium, preferably subspecies paratuberculosis , the causal agent of Johne ' s disease.
  • the invention provides method for detecting a ruminant infected with a causal agent of Johne ' s disease comprising obtaining a sample from said cow and testing said sample for the presence of nucleic acid using at least one nucleic probe or primer, or a method or diagnostic kit according to the invention.
  • the invention provides a method for eradicating Johne ' s disease from a herd of ruminants comprising using a method according to the invention and further comprising culling or removing a ruminant infected with a causal agent of Johne ' s disease ruminant from said herd, after which said ruminant, for example an infected cow, may be destroyed.
  • the invention provides use of a nucleic acid probe or primer allowing detecting nucleic acid derived from Mycobacterium avium whereby nucleic acid derived from Mycobacterium avium subspecies para tuberculosis can be discriminated from nucleic acid derived from other Mycobacterium avium subspecies.
  • a nucleic acid probe or primer allowing detecting nucleic acid derived from Mycobacterium avium whereby nucleic acid derived from Mycobacterium avium subspecies para tuberculosis can be discriminated from nucleic acid derived from other Mycobacterium avium subspecies.
  • Such use is for example to detect a causal agent of Johne' s disease in faecal samples, for example by using a nucleic acid detection method as provided by the invention.
  • Such use allows governmental authorities and individual farmers, veterinarians, and concerned agricultural organisations to eradicate Johne ' s disease from a herd of ruminants, more specifically of cows infected with Mycobacterium avium subspecies para tuberculosis .
  • the invention is further explained in the experimental part of the description without limiting the invention thereto.
  • Total nucleic acids were isolated from colonies grown on Lowenstein-Jensen medium or directly from lyophilized cell pellets as obtained from culture collections. Methods used were as described elsewhere (Aznar et al., 1994. Int. J. System. Bacteriol. 44:330-337).
  • the 23S rRNA genes were amplified by using primers directed towards conserved regions and the genes were sequenced commercially.
  • the 23S rRNA genes were aligned and checked for the presence of Myb . avium subsp. parat ⁇ berculosis-specific sequences. Part of the alignment is displayed in Fig. 1.
  • the paratuberculosis sequence is characterised by the presence of 3 single point-mutations as compared to the avium and silvaticum sequences. These three point-mutations comprise of a transition of C in avium and silvaticum to a T in the paratuberculosis gene. These point mutations can be detected by using the polymerase chain reaction such as described now.
  • PCR detection of point-muta tions was performed on a Eppendorf Mastercycler gradient with a temperature gradient from 55 to 68 degrees centigrade.
  • the PCR reaction mixture (100 ⁇ l) consisted of the following components: 10 ⁇ l of lOx reaction buffer; 0.3 ⁇ l of Taq DNA polymerase (Promega corp.); 2 ⁇ l of both forward and reverse primer @ 100 ⁇ M; 1 ⁇ l of DNA template @ 25 ng/ ⁇ l; 4 ⁇ l of dNTP's and 80,7 ⁇ l of H20.
  • Thermal cycles consisted of a denaturing step at 95°C for 5 min, followed by 35 cycles of 95°C, gradient temp 55-68°C and 72 °C for 1, 2, and 3 min respectively.
  • PCR products were checked by standard agarose gel-electrophoresis in 0.8% agarose gels and stained with ethidium bromide.
  • This invention forms the key element of the diagnostic procedure which comprises at least one of the following steps:
  • Example 1 Cell lysis , ribonucleic acid extraction and RNA amplification from pure cultures of Mycobacterium avium subspecies paratuberculosis .
  • Sybr Green (Molecular Probes, Leiden, The Netherlands) was used as a DNA counter-stain. Briefly, a 10 ⁇ l volume of the washed and fixed cell suspension was added to 1.0 ml of PBS. To this diluted suspension, Sybr Green was added to yield a final concentration of 1/10,000-th of the original manufacturer-stock. Staining occurred at 37 °C for 10 min. After staining, the entire suspension was drawn over a 0,2 ⁇ m pore-size black polycarbonate membrane filter (Millipore, Etten-Leur, The Netherlands).
  • the filters were mounted on a microscope slide and cell counts were determined using an Olympus BX-60 epifluorescence microscope (Paes Nederland BV, Zoeterwoude, The Netherlands) . A minimum of 15 fields-of-view per sample were counted or until the total number of counted cells was 300.
  • RNA extraction and quantification RNA was extracted from pure culture cell suspensions by using three basic methods. Modifications were made to the procedures in case cell lysis of M. para tuberculosis was incomplete. These modifications comprised the inclusion of freeze/thawing cycles or bead-beating procedures. Basic procedures were as directed by the manufacturers of the RNA extraction systems. The following methods were tested for RNA extraction from M. para tuberculosis cells: i) RNA extraction according to the silica-adsorption principle described by Boom et al. (J. Clin. Microbiol. 28, 1990, pp.
  • RNA extraction from M. para tuberculosis cells was further evaluated empirically by NASBA and RT-PCR.
  • NASBA was performed by using the commercial NucliSens Basic Kit system for NASBA diagnostics (Organon Teknika) . Reaction conditions for NASBA amplification of RNA were as directed by the manufacturer. Detection of M. para tuberculosis-specific 23S-rRNA fragments was performed by ECL detection using a biotin labeled probe. Measurements were performed on a NucliSens reader (Organon Teknika) . NASBA primers and probes specific for M. para tuberculosis were designed based on multiple alignments of the complete 23S rRNA gene sequences from 5 M. para tuberculosis and 5 M. avium strains, together with sequences from M. intracellulare and M. silvaticum. Alignments were constructed by using the Multiple Sequence alignment tool from the BCM Search Launcher
  • paratuberculosis were designed based on multiple alignments of the complete 23S rRNA gene sequences from 5 M. para tuberculosis and 5 M. avium strains, together with sequences from M. intracellulare and M. silva ti cum . Alignments were constructed by using the Multiple Sequence alignment tool from the BCM Search Launcher (www.hgsc.bcm.tmc.edu/ SearchLauncher/) . Confirmation of the existence of conserved M.
  • para tuberculosis-specific sequences in the 23S rRNA gene was further evaluated by partial sequencing and by point-mutation PCR (primers with wild-type position at 3' -end) from 12 additional para tuberculosis strains and 3 additional avium strains.
  • the primers used are presented in figure 6. A total of 41 thermal cycles was applied.
  • Sensitivity of the various amplification reactions was determined by using standardized cell-suspensions of M. para tuberculosis in 20% glycerol.
  • M. para tuberculosis-specific 23S-rRNA from TRI-reagent extracted and CF11 purified total RNA was transcribed into cDNA with AMV Reverse Transcriptase (Promega Inc., Leiden, The Netherlands) at 50°C for 90 min. The reaction conditions were as directed by the manufacturer.
  • cDNA sequences were then amplified by PCR. Reaction products were checked for correct length on 1.5% agarose gels using ethidium bromide staining.
  • agarose gels were blotted onto hybond N+ membranes (Amersham Pharmacia) using a vacuum manifold and standard procedures (Sambrook J, Fritch EF and Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Cold Spring Harbor Labi. Press, New York, 1989) .
  • DNA was crosslinked by UV irradiation using a UV crosslinker (Amersham Inc., s Hertogenbosch, The Netherlands) at 700 Joules/cm2. Blots were stored dry until use.
  • blots were hybridized with a fluorescein labeled probe (see figure 6) and stained by NBT-BCIP chromogenic staining and anti- FITC-AP F ab fragments (Roche Diagnostics, Almere, The Netherlands) .
  • Example 2 NASBA amplification and detection of Mycobacterium. paratuberculosis-specific RNA in total RNA extracts from bovine fecal samples.
  • RNA extraction from M. parat ⁇ berculosis-free bovine manure was extracted by using the commercial NucliSens Basic Kit (Organon Teknika) based on silica adsorption.
  • RNA was even further purified by the method of Wilde et al. (J. Clin. Microbiol. 28, 1990, pp. 1300-1307) using the cellulose fiber compound CF-11 (Whatman International Ltd., Clifton NJ, USA). Briefly, isopropanol precipitated total RNA was washed with 75% ethanol and dried for 5 min at room temperature.
  • the pellet was resuspended in a 100 ⁇ l volume of DEPC-treated water and heated to 55°C for 10 min. Upon cooling, extracts were diluted 1:1 with 2 x STE containing 66% ethanol and an amount of 30 mg of CF-11 was added. Samples were placed on a rotating mixer for 45 min at room temperature. After centrifugation and removal of the supernatant, the pellet was washed 3 times with 1 x STE containing 20% ethanol. The RNA was eluted in a 20 ⁇ l volume of 10-50% formamide in DEPC water. The eluate was stored at -20°C until use.
  • RNA extraction from pure cultures of M. paratuberculosis RNA extraction from pure cultures of M. paratuberculosis .
  • NASBA amplification and detection Non-purified total RNA extracts from crude bovine manure were mixed with RNA extracts obtained from pure cultures of M. para tuberculosis in order to investigate the inhibiting effect of fecal matrix compounds on the amplification reaction.
  • Reaction conditions for NASBA amplification were as described in example 1.
  • Various dilutions of non-purified crude manure RNA extract were mixed with RNA extracted from 1,000,000 cells of M. para tuberculosis strain GDR.
  • Non-purified crude manure extract showed a severe inhibitory effect on NASBA amplification of M. para tuberculosis RNA (see figure 10) . This effect could be reduced by administering very low amounts of bovine fecal matrix extract in the amplification reaction or by purification of RNA extract as described.
  • Example 3 NASBA amplification and detection of Mycobacterium paratuberculosis cells in bovine fecal samples .
  • Sample preparation was as described in example 2.
  • RNA extraction from bovine manure spiked with M. paratuberculosis cells was extracted by using the commercial TRI-reagent (Sigma) . Briefly, to a cell pellet obtained from 500, 50 and 5 mg of a crude manure bacterial cell fraction, various amounts of M. paratuberculosis cells ranging from 10,000 to 100 cells were added. The pellets were resuspended in a 1 ml volume of 4% NaOH. The partial lysate was centrifuged at 10,000 x g and the remaining cell pellet was resuspended in 1 ml of TRI- reagent.
  • M. para tuberculosis-specific 23S rRNA' s in the extracts were measured by NASBA amplification and detection as described in example 1. Sensitivity of the assay was between 100 and 1,000 cells per gram of feces (see figure 11) .
  • Example 4 Detection of Mycobacterium paratuberculosis in spiked bovine fecal samples by reverse transcription PCR (RT-PCR) and reverse transcription nested PCR (RT-nested-PCR) .
  • RT-PCR reverse transcription PCR
  • RT-nested-PCR reverse transcription nested PCR
  • Sample preparation was as described in example 2.
  • RNA extraction from bovine manure was extracted from 0,5 grams of the crude manure bacterial fraction described in example 3.
  • RT-PCR and RT-nested-PCR amplification were as described in example 1.
  • a 2 ⁇ l volume of PCR reaction product was added to a second PCR reaction containing the nested primerset (see figure 7) .
  • An additional 41 thermal cycles were applied.
  • nucleic acid amplification When nucleic acid amplification is applied on a large scale, effective programs for decontamination or the prevention of cross-contamination must be installed.
  • the large amounts of amplicon that are generated in the rooms in which the actual amplification step takes place must be contained. Physical separation must be realised between activities of reagent preparation, sample handling and amplification & detection.
  • Another approach is the containment of the source of contamination: the amplification reaction itself. This can be achieved by applying closed- system amplification and detection by which the reaction vessel is never opened again.
  • This enzyme specifically degradates uracyl containing sequences that are incorporated in the amplicon prior to the initiation of new amplification reactions (Ferre et al . , 1996 In : A labora tory guide to RNA . Isola tion , analysis and synthesis . P. A. Krieg, ed. pp. 175-221. Wiley-Liss, New York)
  • the sensitivity of the system is primarily determined by the amount of detectable targets. Such targets can then be amplified by PCR or NASBA. Other methods of amplification are so-called signal amplification methods of which branched DNA (bDNA) and LCR (ligase chain reaction) are examples.
  • Amplification targets can comprise RNA or DNA.
  • RNA target amplification by, e.g., reverse transcriptase PCR (RT-PCR) or NASBA is therefore that these methods are superior in sensitivity than the DNA amplification methods for detection of bacterial cells, e.g., by PCR.
  • RT-PCR reverse transcriptase PCR
  • amplicon detection parts are important in the method of detection of M. para tuberculosis, also the data analysis and specifically the sample pre-treatment are critical processes to be assigned.
  • Sample preparation relates to the liberation of DNA or RNA from M. paratuberculosis cells present in sample .
  • RNA targets are present at much higher frequencies then are DNA targets. Sensitivity is thus improved by using RNA as the starting material for nucleic acid amplification based detection methods. As a result, RT-PCR, NASBA, or TMA technologies are preferred.
  • RT-PCR, NASBA, or TMA technologies are preferred.
  • RMNA targeted fluorescence in situ hybridization (FISH) technology strong fluorescent signals are required for the detection of Myb . avium subsp. para tuberculosis cells in faecal samples by FISH. It may be expected that the slowly growing cells contain very few ribosomes.
  • Signal amplification protocols such as proposed in EP 97.20.2618 can be used to improve the signal in FISH procedures.
  • FISH FISH in situ hybridization
  • M. para tuberculosis cells may require the selective enrichment of M. para tuberculosis cells from the autochthonous background population (e.g., by cultivation or immunomagnetic capture) . Rapid microscopic confirmation of samples that have tested positive by nucleic acid amplification methods can be realised through FISH.
  • the high reliability and confirmation possibilities of FISH and the high sensitivity and speed of the nucleic acid amplification technologies makes parallel development of both FISH and NASBA or RT-PCR extremely valuable.
  • RNA extraction reaction For the extraction of RNA from pure cultures of bacteria or from relatively simple matrices, high-throughput solid phase extraction procedures are commercially available.
  • An important aspect of the RNA extraction reaction is the purity of the final extract.
  • the faecal matrix is known to contain substances that exert significant inhibitory action on the enzymes of nucleic acid amplification technologies that cannot be easily removed from the extract. Bilirubin and bile-salts are known to inhibit the PCR reaction at concentrations as low as 10 to 50 milligrams per millilitre (Widjojoatmodjo et al . , 1992. J Clin Microbiol 30:3195-3199).
  • Several procedures have been developed to improve nucleic acid amplification from the fecal matrix. Among these are
  • glass-matrix precipitation (Stacy-Phipps et al . , 1995. J Clin Microbiol 33:1054-1059) or alternative resins or the use of chaotropic compounds in the extraction (Shieh et al . , 1995. J Virol Methods 54:51-66) can improve enzymatic nucleic acid amplification.
  • the reliability of accurately discriminating between point mutations in amplification reactions can substantially be increased by using competitor primers or, preferably, PCR clamping with PNA ( ⁇ rum, H., et al. 1993. Nucleic Acids Res. 21:5332-5336).
  • Possibilities for detection of the produced amplicon are infinite. Technologies such as the chemiluminescence based hybridization protection (HP) assay with acridinium- esters (AE) (Gen-Probe) , fluorescence based technologies such as the use of molecular beacons (Tyagi and Kramer. 1996. Nature Biotechnol. 14:303-308), Taq-man procedures (Perkin Elmer) , the FRET principle (Roche Diagnostics) or the use of intercalating dyes can be used to detect the amplicons in various ways that all have their own specificities. Sandwich hybridization assays in combination with magnetic bead capture formats can also be applied.
  • the short names represent the following strains: paratGDR, Mycobacterium avium subspecies para tuberculosis strain GDR; par44135, Mycobacterium avium subspecies para tuberculosis strain DSM 44135; parbovE5, Mycobacterium avium subspecies para tuberculosis strain Spbov E5; paratGie, Mycobacterium avium subspecies para tuberculosis strain J2A; parl9698, Mycobacterium avium subspecies para tuberculosis strain ATCC 19698 (Type strain); avi44157, Mycobacterium avium subspecies avium strain DSM 44157; avi25291,
  • Mycobacterium avium subspecies avium strain strain ATCC 25291 (Type strain) ; avi43216, Mycobacterium avium subspecies avium strain DSM 43216; avi44158, Mycobacterium avium subspecies avium strain DSM 44158; MYCAVIUM, Mycobacterium avium subspecies avium strain strain 23435; intl3950, Mycobacterium intracell ulare strain ATTC 13950 (Type strain) ; sil44175, Mycobacterium avium subspecies silvaticum strain DSM 44175 (Type strain) ; 23SEcoli, Escherichia coli 23S rRNA gene sequence Genbank J01695.
  • the first 5 species represent well characterized strains of Mycobacterium avium subsp. para tuberculosis .
  • the next 5 strains represent well characterized strains of Mycobacterium avium subsp. avium .
  • the four mutations that form part of this invention are numbered 754, 1363, 3093 and 3188.
  • the 3188 mutation is positioned in the ITS region between the 23S and 5S rRNA genes.
  • the boxed regions represent the thymine residue in the rRNA operon of Mycobacterium avium subsp. para tuberculosis that form the basis of subspecies-specific detection methods as embodied in the present invention.
  • the figure represents an agarose gel of PCR products obtained after amplification of a portion of the 23S rRNA genes from DNA from Mycobacteriuir- avium subspecies paratuberculosis strain GDR (all upper slots of the gel) and Mycobacterium avium subspecies avium strain 97-613 (all lower slots of the gel) .
  • the primer pair consisted of primer 20F and primer 22R (as described in table 2) .
  • a series of 10 different annealing temperatures was applied by using the eppendorf Master cycler gradient apparatus. From left to right over the gel, PCR products from reactions with increasing annealing temperatures were applied. At an annealing temperature of
  • the figure represents agarose gels of PCR products obtained after amplification of a portion of the 23S rRNA genes from DNA isolated from a large number of well characterized strains as well as field isolates of (presumably) Mycobacterium avium subsp. paratuberculosis (top) and of (presumably) MycoJbacterium avium subsp. avium (bottom) .
  • An annealing temperature of 68 °C was used. No product of the specific length (approximately 600 bases) was obtained from DNA isolated from Mycobacterium avium subsp. avium strains.
  • paratG14, paratG53, paratG63, parat390, parat437, parat442, parat444, parat434, parat421, parat412, parat423, parat424, parat415, and paratG32 were obtained from PCR reactions with DNA from field isolates of Mycobacterium avium subsp. paratuberculosis .
  • the other para tuberculosis strains are coded as described in the legend to figure 1.
  • the codes of the strains used in the lower gel were as described in the legend to figure 1.
  • the codes avi97613 and avi97675 represent field isolates of Mycobacterium avium subsp. avium.
  • Figure 7 Effect of primer design on NASBA amplification of 23S rRNA sequences from M. para tuberculosis .
  • Primerset A was chosen for further studies. By using the optimized primer set, a detection sentitivity of less than 10 cells per ml of buffer could be attained (see text) .
  • Figure 8 Effect of cell lysis on detection of M. para tuberculosis cells by NASBA. By using forced cell disruption or selective lysis much higher detection sensitivities could be attained. TRI-reagent itself could be used as a selective lysis environment.
  • FIG. 9 Southern blots from RT-PCR amplification of RNA extracted from pure cultures of M. para tuberculosis strain GDR by TRI reagent with (above) and without (below) additional bead beating procedures. Detection by RT-PCR is as sensitive as NASBA (i.e., less than 10 cells per ml).
  • Figure 10 Effect of matrix inhibition on the enzymatic amplification of 23S ribosomal RNA sequences of M. para tuberculosis by NASBA.
  • Figure 11. NASBA amplification and detection of M. para tuberculosis cells in bovine manure. Non-target cell lysis was achieved by 4% NaOH treatment. Assay sensitivity was further improved by CF-11 adsorption (see text) .
  • McFadden, J.J., et al . 1987b Determination of genome size and DNA homology between unclassified mycobacterium species isolated from patients with Crohn' s disease and other mycobacteria. J. Gen. Microbiol. 133:211-213.
  • the ribosomal intergenic spacer region a target for the PCR based diagnosis of tuberculosis. Tuber. Lung Dis. 75 (5) : 353-360.
  • Mycobacterium avium subspecies avium strain DSM 44158 Mycobacterium avium subspecies avium strain DSM 43216 Mycobacterium avium subspecies avium strain DSM 44157 Mycobacterium avium subspecies avium strain ATCC 25291 (Type strain)
  • Mycobacterium avium subspecies avium strain 97-613 Mycobacterium avium subspecies silva ticum strain DSM 44175 (Type strain) ycojbacteriufl- intracellulare strain ATTC 13950 (Type strain)
  • Primers for point-mutation PCR The site of the "mutation” is indicated. Primers with code “F” are forward primers, those with code “R” are reverse primers.

Abstract

L'invention concerne le domaine de la microbiologie, notamment le domaine de la détection et de l'identification de micro-organismes pathogènes, et plus particulièrement la détection et l'identification de la sous-espèce paratuberculosis de Mycobacterium avium, laquelle est un agent provoquant la paratuberculose chez bien des ruminants. L'invention concerne un procédé rapide et sensible de détection et d'identification de la sous-espèce paratuberculosis du Mycobacterium avium, dans des échantillons biologiques et naturels, cette sous-espèce pouvant être distinguée d'autres sous-espèces de Mycobacterium avium, telle que la sous-espèce avium.
EP99958512A 1998-12-04 1999-12-03 Detection de sous-especes du mycobacterium avium Withdrawn EP1135523A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP99958512A EP1135523A1 (fr) 1998-12-04 1999-12-03 Detection de sous-especes du mycobacterium avium

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98204117 1998-12-04
EP98204117 1998-12-04
EP99958512A EP1135523A1 (fr) 1998-12-04 1999-12-03 Detection de sous-especes du mycobacterium avium
PCT/NL1999/000741 WO2000034517A1 (fr) 1998-12-04 1999-12-03 DETECTION DE SOUS-ESPECES DU $i(MYCOBACTERIUM AVIUM)

Publications (1)

Publication Number Publication Date
EP1135523A1 true EP1135523A1 (fr) 2001-09-26

Family

ID=8234433

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99958512A Withdrawn EP1135523A1 (fr) 1998-12-04 1999-12-03 Detection de sous-especes du mycobacterium avium

Country Status (5)

Country Link
EP (1) EP1135523A1 (fr)
AU (1) AU776138B2 (fr)
CA (1) CA2353580A1 (fr)
NZ (1) NZ512311A (fr)
WO (1) WO2000034517A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121505A1 (de) * 2001-05-03 2003-01-30 Hain Lifescience Gmbh Verfahren zum Nachweis von Gram-positiven Bakterien
EP1254963A1 (fr) * 2001-05-04 2002-11-06 BioChip Technologies GmbH Acides nucléiques et méthodes pour caractériser les mycobactéries au niveau du genre-, groupe-, espèce-, et sous-espèce
US7074559B2 (en) 2002-03-06 2006-07-11 Refents of the University of Minnesota Mycobacterial diagnostics
WO2008055916A2 (fr) * 2006-11-06 2008-05-15 Universite De Mons Hainaut Nouveaux antigènes permettant le diagnostic de la paratuberculose et la vaccination contre cette dernière
EP2270202A1 (fr) * 2009-07-03 2011-01-05 John Ikonomopoulos Détection mycobactérienne

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2709310B1 (fr) * 1993-07-23 1995-09-29 Bio Merieux Fragment nucléotidique de l'ARN ribosomique 23S de mycobactéries, sondes et amorces dérivées, réactif et procédé de détection.
US5712095A (en) * 1994-06-16 1998-01-27 Becton Dickinson And Company Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors
US5691143A (en) * 1996-03-15 1997-11-25 Becton, Dickinson And Company Amplification and detection of the alpha antigen gene of mycobacterium avium complex species

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0034517A1 *

Also Published As

Publication number Publication date
AU776138B2 (en) 2004-08-26
NZ512311A (en) 2003-08-29
CA2353580A1 (fr) 2000-06-15
AU1586300A (en) 2000-06-26
WO2000034517A1 (fr) 2000-06-15

Similar Documents

Publication Publication Date Title
JP3097059B2 (ja) 標的ヌクレオチド配列に対する特異的プローブの生成
Hill et al. The polymerase chain reaction: applications for the detection of foodborne pathogens
Schonenbrucher et al. New triplex real-time PCR assay for detection of Mycobacterium avium subsp. paratuberculosis in bovine feces
US6723505B1 (en) Method for identification of the indicators of contamination in liquid samples
JPH06502312A (ja) ミコバクテリアの核酸に相補的なオリゴヌクレオチド
AU710387B2 (en) Amplification and detection of mycobacterium avium complex species
KR100388548B1 (ko) 알이피 13 이 12 반복서열의 피시알 증폭을 이용한결핵균의 검출방법
CN112831580A (zh) 一种用于检测副溶血性弧菌dna的反应体系、试剂盒及其应用
Romaniuk et al. Rapid identification of Campylobacter species using oligonucleotide probes to 16S ribosomal RNA
Haigh et al. A novel clinical syndrome and detection of Anaplasma ovis in Mongolian reindeer (Rangifer tarandus)
Hu et al. Simultaneous analysis of foodborne pathogenic bacteria by an oligonucleotide microarray assay
JPH07505535A (ja) カンピロバクタージュジュニ（Ｃａｍｐｙｌｏｂａｃｔｅｒ　ｊｅｊｕｎｉ）のゲノムの核酸の塩基配列と特異的にハイブリダイズするヌクレオチド配列
AU776138B2 (en) Detection of mycobacterium avium subspecies
CA2718214C (fr) Detection des bacteries du genre campylobacter par ciblage de l'enterotoxine cytoletale et distendante
KR100457355B1 (ko) 병원성 미생물의 유전자 증폭용 프라이머, 이를 이용한병원성 미생물의 검출방법, 및 검출키트
KR100436741B1 (ko) 세균 검출용 유전자 및 이를 이용한 세균의 검출방법
Saint et al. A PCR test for the identification and discrimination of Legionella longbeachae serogroups 1 and 2
EP1888745A2 (fr) Fragments d'adn, amorces et methode d'amplification des fragments d'adn, trousse comprenant lesdites amorces utilisee pour la detection et l'identification d'especes candida presentant une pertinence clinique
Shivachandra et al. Molecular diagnostic approaches for haemorrhagic septicaemia [HS]: A Review
WO2019221219A1 (fr) Procédé d'examen d'une bactérie, micropuce pour l'examen d'une bactérie, kit d'examen de bactérie, ensemble des sondes pour l'examen d'une bactérie et ensemble d'amorces pour l'examen d'une bactérie
Stackebrandt et al. Towards a molecular identification of Streptomyces species in pure culture and in environmental samples
Günther et al. Design and evaluation of an oligonucleotide-microarray for the detection of different species of the genus Kitasatospora
CN105256042B (zh) 对亲水气单胞菌o13，o36，o16和o19特异的核苷酸及应用
Le Roux et al. Evaluation of a rapid polymerase chain reaction based identification technique for Vibrio cholerae isolates
JP4477741B2 (ja) マイコプラズマ属およびウレアプラズマ属の細菌の検出方法並びにマイコプラズマ属およびウレアプラズマ属の菌種の同定方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20031128

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060404